Urinary Bladder Neoplasms Clinical Trials

Recruiting

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

NCT07206225

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States

UAB Infusion Therapy Extended Care Clinic (ECC) Birmingham, Alabama, United States

The University of Alabama at Birmingham Investigation Drug Services Pharmacy Birmingham, Alabama, United States

University of Alabama at Birmingham Birmingham, Alabama, United States

View all 68 locations

View Trial Details

Recruiting

Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy

NCT07144319

Conditions: Bladder Cancer, Carcinoma, Female Urogenital Diseases, +14 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

Regents of the University of Michigan Ann Arbor, Michigan, United States

Rutgers Cancer Institute New Brunswick, New Jersey, United States

Oslo University Hospital Oslo, Norway

View Trial Details

Recruiting

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

NCT07090499

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, +50 more
Locations: City of Hope National Medical Center Duarte, California, United States

City of Hope at Irvine Lennar Irvine, California, United States

Ronald Reagan UCLA Medical Center Los Angeles, California, United States

UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States

View all 31 locations

View Trial Details

Recruiting

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

NCT06644755

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Liposarcoma, +17 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center New York, United States

Sarah Cannon Research Institute Nashville, Tennessee, United States

UZ Leuven Europe Leuven Leuven, Belgium

View Trial Details

Recruiting

Relevance of the Urine Bacterial Culture Performed Before TransUrethral Resection of the Bladder for Post-operative Febrile Urinary Tract Infections Prevention: a Non-inferiority Randomized Controlled Trial

NCT07463963

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: Centre Hospitalier Universitaire d'Angers Angers, France

Centre Hospitalier Universitaire de Grenoble Alpes Grenoble, France

Centre Hospitalier de Chartres - Hôpital Louis Pasteur Le Coudray, France

Centre Hospitalier Universitaire de Lille Lille, France

View all 15 locations

View Trial Details

Recruiting

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

NCT06567743

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, High-Risk Non-Muscle-Invasive Bladder Cancer, +9 more
Locations: Mayo Clinic Arizona Phoenix, Arizona, United States

Arizona Urology Specialty Tucson, Arizona, United States

University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Arkansas Urology Little Rock, Arkansas, United States

View all 80 locations

View Trial Details

Recruiting

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

NCT06760819

Conditions: Adnexal Diseases, Advanced Solid Tumors, Biliary Tract Diseases, +53 more
Locations: UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States

City of Hope - Duarte Cancer Center Duarte, California, United States

Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus Fort Myers, Florida, United States

Dana-Farber Cancer Institute - Oncology Department Boston, Massachusetts, United States

View all 54 locations

View Trial Details

Recruiting

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

NCT05334069

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +137 more
Locations: Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States

Alaska Oncology and Hematology LLC Anchorage, Alaska, United States

View all 745 locations

View Trial Details

Recruiting

The Vanguard Study: Testing a New Way to Screen for Cancer

NCT06995898

Conditions: Adenocarcinoma, Adnexal Diseases, Bladder Carcinoma, +64 more
Locations: Kaiser Permanente-Division of Research Pleasanton, California, United States

Keefe Memorial Hospital Cheyenne Wells, Colorado, United States

Kaiser Permanente-Franklin Denver, Colorado, United States

Poudre Valley Hospital Fort Collins, Colorado, United States

View all 44 locations

View Trial Details

Recruiting

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

NCT05837767

Conditions: Adenocarcinoma, Bladder Cancer, Breast Diseases, +65 more
Locations: Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited protocol activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) Commack, New York, United States

View Trial Details

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms trial results

Related conditions